ACG's Committees (cont.) PRACTICE PARAMETERS COMMITTEE MEMBERS David W. Wan, MD, FACG, Chair Neil Sengupta, MD, FACG, Vice Chair Jana G. Al Hashash, MD, FACG Andrea L. Betesh, MD Kathy P. Bull-Henry, MD, MBA, FACG Brooks D. Cash, MD, FACG Adam S. Cheifetz, MD, FACG Steven B. Clayton, MD, FACG Nayantara Coelho-Prabhu, MD, FACG Michelle S. Cohen, MD Shashank Garg, MD Mohit Girotra, MD Katarina B. Greer, MD, MS Epi Ira M. Jacobson, MD, FACG Sofia S. Jakab, MD
Arun B. Jesudian, MD, FACG Janice Jou, MD Jonathan S. Levine, MD Berkeley Nguyen Limketkai, MD, PhD, FACG Millie D. Long, MD, MPH, FACG John G. McCarthy, MD Douglas R. Morgan, MD, MPH, FACG Sravanthi Parasa, MD Amit Patel, MD, FACG Anjana A. Pillai, MD, FACG Mark S. Riddle, MD, DrPH, FISTM Douglas J. Robertson, MD, MPH Bryan G. Sauer, MD, MSc (Clin Res), FACG Shervin Shafa, MD Brijen J. Shah, MD
RESPONSIBILITIES AS STATED IN THE ACG BYLAWS This Committee shall be responsible for reviewing state-ofthe-art research and establishing peer-reviewed consensus recommendations for publication by the College regarding the then-current viewpoint of several key experts on the treatment of digestive disorders by gastroenterologists and other physicians.
OBJECTIVES
Sunil G. Sheth, MD, FACG Eun J. Shin, MD Humberto Sifuentes, MD Ashwani K. Singal, MD, MS, FACG Preetika Sinh, MD Zachary L. Smith, DO Amir Soumekh, MD Jason R. Taylor, MD, FACG Chandrashekhar Thukral, MD, PhD Adam M. Tritsch, MD Jamile Wakim-Fleming, MD, FACG Robert J. Wong, MD, MS, FACG Rena H. Yadlapati, MD, MSHS Mohammad Yaghoobi, MD, FACG
David W. Wan, MD, FACG
• Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury (May 2021) • Prevention, Diagnosis, and Treatment of Clostridioides difficile Infections (June 2021) The following four guidelines are undergoing revisions or are nearing completion: • Management of Benign Anorectal Disorders
1. Develop practice guidelines that reflect the current, state-ofthe-art scientific work based on the principles of evidencebased medicine.
• Diagnosis and Management of Barrett’s Esophagus
2. Update previously published guidelines as new information becomes available.
• Diagnosis and Management of Gastroesophageal
• Acute On Chronic Liver Failure
The following seventeen guidelines are currently in development:
COMMITTEE REPORT
• Acute Liver Failure
This year again was very productive for the Practice Parameters Committee. At the time of this report, five practice guidelines were published in The American Journal of Gastroenterology (AJG) in 2021, four guidelines are being reviewed or are nearing completion, and twenty guidelines are in development.
• Acute Lower GI Bleeding
The following five guidelines were published in AJG in 2021:
• Barrett’s Esophagus
• Acute Pancreatitis [Update] • Alcohol-Associated Liver Disease • Approach to Submucosal Masses of the GI Tract
• Management of Irritable Bowel Syndrome (January 2021)
• Bariatric Endoscopy
• Colorectal Cancer Screening 2021 (March 2021)
• Biliary Strictures
• Upper Gastrointestinal and Ulcer Bleeding (May 2021)
• Celiac Disease [Update]
76 | 2020–2021 ACG AWARDS & LEADERSHIP
